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Abstract
Purpose The aim of this study was to systematically review
and metaanalyze published data on the diagnostic perfor-
mance of 18F-fluoro-2-deoxyglucose positron emission
tomography (FDG-PET) in detecting prosthetic hip or knee
joint infection.
Methods A systematic search for relevant studies was
performed of the PubMed/MEDLINE and Embase data-
bases. Two reviewers independently assessed the method-
ological quality of each study. A metaanalysis of the
reported sensitivity and specificity of each study was
performed. Subgroup analyses were performed if results
of individual studies were heterogeneous.
Results The inclusion criteria were met by 11 studies; there
was a total sample size of 635 prostheses. Overall, the
studies had good methodological quality. Pooled sensitivity
and specificity of FDG-PET for the detection of prosthetic
hip or knee joint infection were 82.1% (95%CI=68.0–
90.8%) and 86.6% (95%CI=79.7–91.4%), respectively.
Heterogeneity among the results of individual studies was
present (I2=68.8%). Diagnostic performance was influ-
enced by type of joint prostheses (hip prostheses vs. knee
prostheses) and type of reconstruction method used (filtered
back vs. iterative) (p=0.0164 and p=0.0235, respectively).
Conclusion In this metaanalysis, overall diagnostic perfor-
mance of FDG-PET was moderate to high. Caution is
warranted, however, because results of individual studies
were heterogeneous and could not be fully explored. Future
studies should further explore potential causes of heteroge-
neity and validate the use of FDG-PET for diagnosing
prosthetic joint infection.
Keywords FDG-PET. Prosthesis . Arthroplasty . Hip .
Knee . Infection
Introduction
Periprosthetic infection following total hip or knee arthro-
plasty is associated with significant morbidity and costs [1–
3]. The infection rates following primary implantation and
revision surgery are approximately 1% and 3% for hip
prostheses and 2% and 5% for knee prostheses, respectively
[4]. Differentiating prosthetic joint infection from aseptic
loosening is of crucial importance for appropriate patient
management; the treatment of an infected joint prosthesis
generally involves both systemic antibiotics for an extended
period and exchange arthroplasty in one or two stages,
whereas aseptic loosening usually requires a single revision
arthroplasty [1, 2]. Diagnosing prosthetic joint infection is
difficult; clinical signs and symptoms, laboratory tests,
radiography, and joint aspiration are insensitive, nonspecif-
ic, or both [5]. In addition, cross-sectional imaging
modalities such as CT and MRI are hampered by artifacts
produced by the prosthetic devices themselves [5]. Radio-
nuclide imaging is less affected by metallic implants and
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may be more useful [5]. Combined leukocyte–marrow
scintigraphy has been reported to achieve a diagnostic
accuracy of 90% or greater and is currently regarded as the
imaging modality of choice for diagnosing prosthetic joint
infection [5]. However, combined leukocyte–marrow scin-
tigraphy is labor-intensive, time-consuming, not widely
available, and potentially hazardous because of direct
handling of blood products [5]. 18F-fluoro-2-deoxyglucose
positron emission tomography (FDG-PET) enables visual-
ization of hyperglycolytic inflammatory cells (leukocytes,
macrophages, and other immunologically active cells)
during infection; it may be an attractive alternative to
combined leukocyte–marrow scintigraphy because it
requires only one injection and scan and is more widely
available [5]. Furthermore, treatment with antibiotics is not
likely to affect the sensitivity of FDG-PET in delineating
sites of infections because FDG does not rely on leukocyte
migration, in contrast to combined leukocyte–marrow
scintigraphy. However, controversial results have been
reported on the diagnostic value of FDG-PET in detecting
prosthetic joint infection and its utility is still under debate.
The purpose of this study was, therefore, to systematically
review and metaanalyze published data on the diagnostic
performance of FDG-PET in detecting prosthetic hip or
knee joint infection and to provide more insight into the
causes of the controversial results in the literature.
Materials and methods
Search strategy
A computer-aided search of the PubMed/MEDLINE and
Embase databases was conducted to find relevant published
articles on the diagnostic performance of FDG-PET in
detecting prosthetic hip or knee joint infection. The search
strategy is presented in Table 1. No beginning date limit
was used. The search was updated until 27 May 2008. To
expand our search, bibliographies of articles which finally
remained after the selection process were screened for
potentially suitable references.
Study selection
Studies investigating the diagnostic performance of FDG-
PET in detecting prosthetic hip or knee joint infection were
eligible for inclusion. All reference standards used in the
individual studies were accepted; however, when FDG-PET
itself was part of the reference standard, the study was
excluded. No language restriction was applied. Review
articles, metaanalyses, abstracts, editorials or letters, case
reports, guidelines for management, studies examining 15
or fewer patients with hip and/or knee prosthesis, studies
performed in animals, and ex vivo studies were excluded.
Studies that examined FDG with a gamma camera in
coincidence mode were also excluded. Studies which
provided insufficient data to construct a 2×2 contingency
table to calculate sensitivity and specificity for detecting
prosthetic hip or knee joint infection were excluded. When
data were presented in more than one article, the article
with the largest number of patients or the article with the
most details was chosen.
Two researchers (T.C.K., R.M.K.) independently
reviewed the titles and abstracts of the retrieved articles,
applying the inclusion and exclusion criteria mentioned
above. Articles were rejected if they were clearly ineligible.
The same two researchers then independently reviewed the
full-text version of the remaining articles to determine their
eligibility for inclusion. Disagreements were resolved in a
consensus meeting.
Study quality
The methodological quality of the included studies was
assessed in terms of the potential for bias (internal validity)
and lack of generalizability (external validity). For this
purpose, a checklist adapted from Kelly et al. [6] and
Whiting et al. [7, 8] was used. The complete criteria list is
presented in Table 2. Internal validity criteria and external
validity scores were scored as positive (adequate methods)
or negative (inadequate methods, potential bias). If insuf-
ficient information was provided on a specific item, a
negative score was given. Two reviewers (T.C.K., R.M.K.)
Table 1 Search strategy and results as on 27 May 2008
No. Search string PubMed/MEDLINE Embase
1 Fluorodeoxyglucose or 2-fluoro-2-deoxy-D-glucose or FDG or positron emission
tomography or positron-emission tomography or PET
41,327 47,571
2 Arthroplasty or arthroplasties or arthroplastic or prosthesis or prostheses or prosthetic
or endoprosthesis or endoprostheses or endoprosthetic
309,295 103,843
3 Infection or infectious or infected or septic or septically 1,078,831 922,906
4 No. 1 and no. 2 and no. 3 98 104
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independently assigned the scores. Disagreements between
the two researchers were discussed and resolved by
consensus. Subtotals were calculated for internal (maxi-
mum six) and external (maximum five) validity separately.
Total quality scores were expressed as a percentage of the
maximum score.
Data analysis
Sensitivities and specificities of FDG-PET for the detection
of prosthetic hip or knee joint infection (with corresponding
95%CIs) were calculated from the original numbers given
in the included studies. Similarly, diagnostic odds ratios
(DORs) of individual studies were calculated. The DOR is
a single overall indicator of diagnostic performance and is,
unlike sensitivity and specificity, independent of any
threshold (cutoff) value [9]. In order to enable calculation
of the DOR, a standard correction of adding 0.5 to all cells
of the 2×2 contingency table was applied if the true-
positive rate, false-positive rate, false-negative rate, or true-
negative rate was zero. DORs of included original studies
were displayed using forest plots.
Metaanalysis was performed using a bivariate random
effects approach to pool the sensitivity and specificity [10].
This model assumes a bivariate normal distribution for the
logit-transformed sensitivity and specificity values across
studies, allowing for heterogeneity beyond chance due to
clinical or methodological differences between studies. It
incorporates and estimates the correlation that might exist
between estimates of sensitivity and specificity within
studies. A standard correction of adding 0.5 to all cells of
the 2×2 contingency table was applied if the true-positive
rate, false-positive rate, false-negative rate, or true-negative
rate was zero. Estimates of the mean logit-transformed
sensitivity and specificity were then obtained. Pooled
estimates of sensitivity and specificity with 95%CIs were
calculated after antilogarithm transformation of these logit
estimates. To improve visualization of the results, the 95%
coverage region of the estimated bivariate distribution of
the logit sensitivity and specificity was transformed back to
receiver operating characteristic (ROC) axes [10]. Results
of the included studies were also plotted in ROC space.
Heterogeneity among the results of individual studies
was tested by subjecting the DORs of individual studies to
the Higgins and Thompson test, calculating the I2 statistic
[11]. If the DOR is equal across studies, the only cause of
heterogeneity is a difference in cutoff levels for prosthetic
joint infection. If the DOR varies across studies, factors
other than cutoff differences exist as well [9]. Heterogeneity
was defined as I2>50%. Potential sources for heterogeneity
were explored by subgroup analysis. Covariates analyzed
were: study design (reported prospective study design vs.
no or unreported prospective study design), way of patient
recruitment (consecutive or random selection of patients vs.
nonconsecutive, nonrandom selection, or unreported way of
recruitment), patient spectrum (inclusion of only symptom-
atic prostheses vs. inclusion of both symptomatic and
asymptomatic prostheses), type of joint prostheses (hip
prostheses only vs. knee prostheses only), age of prostheses
(only inclusion of prostheses older than 6 months vs.
prostheses younger than 6 months were [also] included),
reconstruction method (iterative reconstruction vs. filtered
back projection), type of PET images reviewed (non-
attenuation-corrected [NAC] images only or both NAC
and attenuation-corrected [AC] images vs. AC images
only), and way of image review (reported blinding to
reference test vs. no or unreported blinding to reference
test). Another important issue that requires subgroup
analysis is the use of different criteria to diagnose prosthetic
joint infection. Applied criteria for positivity can grossly be
Table 2 Criteria list used to assess the methodological quality of the studies
Criteria of validity Positive score
Internal validity Prospective study Mentioned in publication
Avoidance of withdrawal bias <10% of patients who were examined by the index test did not
undergo the reference test
Avoidance of study examination bias <10% of indeterminate or uninterpretable results
Avoidance of diagnostic review bias Blind interpretation of index test without knowledge of reference test
Avoidance of test review bias Blind interpretation of reference test without knowledge of index test
Avoidance of comparator review bias Blinding index test to the other imaging modality, if more than one
imaging modality was investigated
External validity Avoidance of spectrum bias Only prostheses suspected of being infected were included
(symptomatic prostheses only)
Demographic information Study location (country), age, and sex of patients reported
Avoidance of selection bias Consecutive series of patients or random selection of patients
Standard execution of index test Application of the same hardware and imaging protocol in all patients
Avoidance of observer variability bias Interpreter(s) of index test described
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divided into four groups: (a) FDG uptake in the peripros-
thetic soft tissue; (b) increased FDG uptake at the bone–
prosthetic interface (BPI); (c) increased FDG uptake at the
BPI, while emphasizing that FDG uptake limited to the soft
tissues adjacent to the neck of the prosthesis is not
considered suggestive of infection (for hip prostheses only);
and (d) other criteria. With regard to these criteria of
positivity, subgroup analyses were performed as follows:
(a) vs. (b, c, or d), (b or c) vs. (a or d), (b) vs. (a, c, or d),
and (c) vs. (a, b, or d) (for studies or subsets in studies on
hip prostheses only). Each of the predefined covariates was
separately included in the bivariate model to compare the
overall sensitivity and overall specificity between different
strata, using a z test with the level of statistical difference
set at 0.05.
Statistical analyses were executed using Meta-DiSc
statistical software version 1.4 (Unit of Clinical Biostatis-
tics, Ramón y Cajal Hospital, Madrid, Spain) and SAS




The computer-aided search revealed 98 articles from
PubMed/MEDLINE and 104 articles from Embase (Table 1).
Reviewing titles and abstracts from PubMed/MEDLINE
revealed 20 articles potentially eligible for inclusion [12–
31]. Reviewing titles and abstracts from Embase revealed
17 articles potentially eligible for inclusion, which were all
already identified by the PubMed/MEDLINE search. Thus,
20 studies remained for possible inclusion and were
retrieved in full-text version. After reviewing the full
article, five articles [18, 21, 22, 25, 26] were excluded
because the same data were used in another article
comprising a larger number of patients, one article was
excluded because it did not investigate the diagnostic
performance of FDG-PET in detecting prosthetic hip or
knee joint infection [14], one article [16] was excluded
because the same data were used in another article
providing more study details, one article [29] was excluded
because less than 15 patients with hip and/or knee
prosthesis were investigated, and one article [31] was
excluded because it appeared to be an abstract only.
Screening references of the remaining articles resulted in
one other potentially relevant article [32]. However, this
article was excluded because less than 15 patients with hip
and/or knee prostheses were investigated [32]. Thus,
eventually 11 studies [12, 13, 15, 17, 19, 20, 23, 24, 27,
28, 30], comprising a total sample size of 635 prostheses,
met all inclusion and exclusion criteria, and they were
included in this systematic review. The characteristics of the
included studies are presented in Tables 3, 4, and 5.
Methodological quality assessment
Methodological quality was assessed by 11 items. The
scores for internal and external validity are presented in
Table 6. The total score for combined internal and external
validity, expressed as a fraction of the maximum score,
ranged from 45% to 91% (median 82%).
Diagnostic performance
The results of the 11 included studies are presented in
Table 7, their DORs are displayed in Fig. 1, and the
corresponding ROC plot is displayed in Fig. 2. Stumpe et
al. [20] provided two results (Table 5), but only the first
result of their study was used for metaanalysis and
assessment of heterogeneity. Sensitivity and specificity of
Table 3 Patient characteristics of included studies









Chryssikos et al. [12], 2008 USA 113 59 (31–87) 54:59 127 (H) 12, 18, and 24 months
Garcia-Barrecheguren et al. [13], 2007 Spain 24 68 (37–81) 12:12 24 (H) >6 months
Pill et al. [15], 2006 USA 89 NR (29–85) NR 92 (H) NR
Delank et al. [17], 2006 Germany 27 NR (45–82) NR 36 (H+K) 0.8–19.4 years (n=27); NR (n=9)
Reinartz et al. [19], 2005 Germany 63 68 (43–88) 32:31 92 (H) 1–31 years
Stumpe et al. [20], 2004 Switzerland 35 69 (46–89) 23:12 35 (H) 12–260 months
Chacko et al. [23], 2003 USA NR NR NR 53 (H)+36 (K) NR
Vanquickenborne et al. [24], 2003 Belgium 17 NR (42–77) 8:9 17 (H) 2–163 months
Manthey et al. [27], 2002 Germany 23 70 (35–83) 9:14 14 (H)+14(K) NR
Van Acker et al. [28], 2001 Belgium 21 66 (33–78) 8:13 21 (K) 7 months–9 years
Zhuang et al. [30], 2001 USA 62 NR (27–81) NR 38 (H)+36 (K) 3 months–8 years
H hip prostheses, K knee prostheses, NR not reported
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FDG-PET for the detection of prosthetic hip or knee joint
infection ranged from 22.2% to 100% and from 61.5% to
100% with pooled estimates of 82.1% (95%CI=68.0–
90.8%) and 86.6% (95%CI=79.7–91.4%), respectively.
Heterogeneity among the DORs of individual studies was
present (I2=68.8%). Overall specificity of FDG-PET in hip
prostheses was significantly higher than that in knee
prostheses (89.8% vs. 74.8%, p=0.0164). Overall specific-
ity of studies using filtered back projection was significant-
ly higher than that of studies using iterative reconstruction
(98.3% vs. 82.3%, p=0.0235). No statistically significant
differences were observed in sensitivities and/or specific-
ities within the subgroups study design (reported prospec-
tive study design vs. no or unreported prospective study
design), way of patient recruitment (consecutive or random
selection of patients vs. nonconsecutive, nonrandom selec-
tion or unreported way of recruitment), patient spectrum
(inclusion of only symptomatic prostheses vs. prostheses
younger than 6 months were also included), age of
prostheses (only inclusion of prostheses older than 6 months
vs. prostheses younger than 6 months were [also] included),
type of PET images reviewed (NAC images only or both
NAC and AC images vs. AC images only), way of image
review (reported blinding to reference test vs. no or
unreported blinding to reference test), and criteria for
positivity (four different comparisons) (Table 8).
Table 6 Quality assessment of included studies
Study and year Criteria Total scores Percentage of maximum score
IV EV IV EV
1 2 3 4 5 6 1 2 3 4 5
Chryssikos et al. [12], 2008 + + + + − + + + + + − 5 4 82
Garcia-Barrecheguren et al. [13], 2007 + + + + − + + + − + + 5 4 82
Pill et al. [15], 2006 + + + + − + + − − + + 5 3 73
Delank et al. [17], 2006 + + + + − + − − − + + 5 2 64
Reinartz et al. [19], 2005 + + + + − + − + + + + 5 4 82
Stumpe et al. [20], 2004 + + + + − + + + + + + 5 5 91
Chacko et al. [23], 2003 − + + − − + + − − − + 3 2 45
Vanquickenborne et al. [24], 2003 + + + + − + + + − + + 5 4 82
Manthey et al. [27], 2002 − + + − − + + + + + + 3 5 73
Van Acker et al. [28], 2001 + + + + − − + + + + + 4 5 82
Zhuang et al. [30], 2001 − + + + − + + − − − + 4 2 55
Table 7 Results of included studies
Study and year Sensitivity (%) Specificity (%)
Value 95%CI Value 95%CI
Chryssikos et al. [12], 2008 84.9 69.1–93.4 92.6 85.4–96.4
Garcia-Barrecheguren et al. [13], 2007 63.6 35.4–84.8 61.5 35.5–82.3
Pill et al. [15], 2006 95.2 77.3–99.2 93.0 84.6–97.0
Delank et al. [17], 2006 40.0 11.8–76.9 100 89.0–100
Reinartz et al. [19], 2005 93.9 80.4–98.3 94.9 86.1–98.3
Stumpe et al. [20], 2004 33.3a 12.1–64.6a 80.8a 62.1–91.5a
22.2b 6.3–54.7b 84.6b 66.5–93.9b
Chacko et al. [23], 2003 91.7 74.2–97.7 89.2 79.4–94.7
Vanquickenborne et al. [24], 2003 87.5 52.9–97.8 77.8 45.3–93.7
Manthey et al. [27], 2002 100 51.0–100 100 86.7–100
Van Acker et al. [28], 2001 100 61.0–100 73.3 48.1–89.1
Zhuang et al. [30], 2001 90.5 71.1–97.4 81.1 68.6–89.4
Pooled estimate 84.6 71.0–92.5 84.0 68.0–92.8
a Reader 1
b Reader 2
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Discussion
This systematic review and metaanalysis included 11
studies comprising a total sample size of 635 prostheses.
Overall methodological quality of included studies was
good. Metaanalytically, FDG-PET achieves moderate to
high sensitivity and specificity in detecting prosthetic hip or
knee joint infection. However, this result should be
interpreted cautiously because significant heterogeneity
was identified among the results of individual studies.
Several causes may underlie this heterogeneity and explain
the controversial results in the literature. Subgroup analysis
revealed that overall specificity of FDG-PET in hip
prostheses was significantly higher than that in knee
prostheses, and overall specificity of studies using filtered
back projection was (inexplicably) significantly higher than
that of studies using iterative reconstruction (Table 8). The
lower specificity of FDG-PET in knee prostheses may be
related to the relatively limited knowledge about the
incidence and pattern of nonspecific FDG uptake around
knee prostheses. Zhuang et al. [33] reported that increased
FDG uptake around the femoral head and neck (possibly
due to foreign body reaction to the material of the
prosthetic joint) may persist for years following hip
arthroplasty and can occur in both symptomatic and
asymptomatic patients; it should not be interpreted as
periprosthetic infection. Increased FDG uptake around the
distal tip of the hip prosthesis is also nonspecific. However,
FDG uptake along the interface between bone and hip
prosthesis is virtually never seen in asymptomatic patients
or in those with aseptic loosening and is, therefore, highly
suggestive of infection [33]. Persistently increased nonspe-
cific FDG uptake following knee arthroplasty has also been
mentioned [33], but should be further investigated. More
knowledge about the incidence and pattern of nonspecific
FDG uptake around knee prostheses may improve the
specificity of FDG-PET in detecting prosthetic knee joint
infection. Despite the findings of Zhuang et al. [33], our
subgroup analysis did not reveal any significantly higher
sensitivity or specificity among studies which used FDG
uptake at the BPI as criterion for positivity, while
emphasizing that FDG uptake limited to the soft tissues or
adjacent to the neck of the prosthesis was not considered
suggestive of infection (Table 8). Metallic prosthetic
material can cause artifacts on attenuation-corrected FDG-
PET images and may also affect diagnostic performance.
Goerres et al. [34] reported that the use of attenuation
correction (both 68Ge-based and CT-based) generates
artifacts of apparently increased FDG concentration around
metallic hip implants. The shape of the prosthesis, the
absorption properties of the surrounding tissues, and the
method of transmission scanning (68Ge-based or CT-based)
influence the appearance of such artifacts. It should be
noted that all evidence regarding the diagnostic perfor-
mance of FDG-PET in prosthetic joint infection has been
acquired using stand-alone PET scanners, which use a



















Fig. 2 ROC plot with pooled sensitivity and specificity (including
95% confidence ellipses) and results of included original studies for
the detection of prosthetic hip or knee joint infection using FDG-PET
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radionuclide source for attenuation correction. Combined
PET/CT is replacing the stand-alone PET scanner in clinical
practice, but may perform differently because it uses CT-
based attenuation correction; this important issue should be
further investigated. Goerres et al. [34] further reported that
patient movement worsens attenuation artifacts, whereas
attenuated-weighted iterative reconstruction appears to
reduce the visibility of artifacts [34]. The presence of
artifacts on attenuation-corrected images has also been
observed in knee prostheses; in a phantom study, Van
Acker et al. [28] showed that artifacts mimicking FDG
uptake adjacent to a knee prosthesis can arise in attenua-
tion-corrected images obtained with different methods of
image reconstruction. In addition, Heiba et al. [35] reported
the observation of an artifact within the joint space of total
knee metallic prostheses in two patients on attenuation-
corrected images. No uptake, however, was noted in the
same location on the nonattenuation-corrected images [35].
Thus, verification of attenuation-corrected images against
nonattenuation-corrected images may avoid false-positive
results because of the abovementioned reasons. However,
our subgroup analysis did not reveal any significantly lower
sensitivity or specificity in the study which exclusively
evaluated attenuation-corrected images (Table 8). In addi-
tion, no statistically significant differences in diagnostic
performance were observed in the subgroup analyses
according to study design, way of patient recruitment,
patient spectrum, age of prostheses, and way of image
review (Table 8). It should be noted, however, that results
from our subgroup analysis may not be conclusive because
of the relatively small number of included studies.
Furthermore, it was not possible to perform subgroup
Table 8 Results of bivariate analysis with covariates











1. Reported prospective study design 8 77.0 0.1629 86.3 0.8335
2. No or unreported prospective study design 3 91.7 87.7
1. Consecutive or random selection of patients 5 77.6 0.6073 89.8 0.1970
2. Nonconsecutively, nonrandom selection,
or unreported method of recruitment
6 84.0 81.8
1. Inclusion of only symptomatic prostheses 9 83.4 0.7527 85.1 0.0955
2. Inclusion of both symptomatic and asymptomatic prostheses 2 78.2 95.2
1. Hip prostheses only 9 82.6 0.3924 89.8 0.0164
2. Knee prostheses only 4 90.4 74.8
1. Only inclusion of prostheses older than 6 months 4 70.2 0.3915 80.3 0.3103
2. Prostheses younger than 6 months were (also) included 4 84.2 89.2
1. Iterative reconstruction method 7 82.0 0.4112 82.3 0.0235
2. Filtered back projection method 2 63.0 98.3
1. Review of NAC images only or both NAC and AC images 3 73.7 0.8235 79.0 0.2021
2. Review of AC images only 1 63.6 61.5
1. Reported blind interpretation of FDG-PET to reference test 9 79.6 0.2203 85.2 0.3461
2. No or unreported blind interpretation of FDG-PET
to reference test
2 91.6 92.0
1.Criterion (a) for positivity only 2 78.2 0.7527 95.2 0.0955
2.Criteria (b), (c), or (d) for positivity 9 83.4 85.1
1.Criteria (b) or (c) for positivity 6 85.1 0.5209 87.5 0.7355
2.Criteria (a) or (d) for positivity 5 76.9 85.1
1.Criterion (b) for positivity only 3 66.8 0.2650 83.0 0.5410
2.Criteria (a), (c), or (d) for positivity 8 85.0 87.7
1.Criterion (c) for positivity only (for studies or
subsets in studies on hip prostheses only)
4 89.7 0.2224 93.1 0.0887
2.Criteria (a), (b), or (d) for positivity (for studies
or subsets in studies on hip prostheses only)
5 76.3 84.6
Applied criteria for positivity divided into four groups: (a) FDG uptake in the periprosthetic soft tissue, (b) increased FDG uptake at the BPI, (c)
increased FDG uptake at the BPI, while emphasizing that FDG uptake limited to the soft tissues adjacent to the neck of the prosthesis is not
considered suggestive of infection (for hip prostheses only), (d) other criteria
AC attenuation-corrected, BPI bone–prosthesis interface, FDG 18 F-fluoro-2-deoxyglucose, NAC nonattenuation-corrected, PET positron emission
tomography
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analyses according to FDG dose, time interval between
FDG administration and scanning, acquisition time for
emission scans, number and experience of interpreters,
reference standard used, and way of interpreting the
reference test because no (meaningful) stratifications could
be made of the available data of included studies. A large
multicenter study is required to further investigate potential
sources of heterogeneity and validate the use of FDG-PET
for diagnosing prosthetic joint infection. Another drawback
of this metaanalysis is the use of different (imperfect)
reference standards in the individual studies (Table 5),
which may have lead to misclassification bias and may
have affected the estimates of diagnostic performance of
FDG-PET. However, because no perfect reference test
exists yet for detecting prosthetic joint infection and all
studies used a combination of reference standards (Table 5),
we accepted this shortcoming.
Combined leukocyte–marrow scintigraphy is currently
regarded as the imaging modality of choice for diagnosing
prosthetic joint infection [5]. Two studies made a direct
comparison between FDG-PET and combined leukocyte–
marrow scintigraphy [15, 28]. Pill et al. [15] investigated 89
patients for revision of painful hip prosthesis. Of the 89
patients, 46 underwent both FDG-PET and combined
leukocyte–marrow scintigraphy for a total of 51 hip
prostheses. Although FDG-PET and combined leukocyte–
marrow scintigraphy demonstrated comparable specificities
(93% and 95.1%, respectively), FDG-PET exhibited a
substantially higher sensitivity (95.2% and 50%, respec-
tively) [15]. Van Acker et al. [28] investigated 21 patients
with a painful knee arthroplasty. All patients underwent
FDG-PET and 20 of 21 patients underwent combined
leukocyte–marrow scintigraphy. Sensitivity and specificity
of FDG-PET were 100% and 73%, respectively, and
sensitivity and specificity of combined leukocyte–marrow
scintigraphy were 100% and 93%, respectively [28]. Based
on this small number of studies [15, 28], however, no
definite conclusion can be drawn yet on the diagnostic
performance of FDG-PET compared to that of combined
leukocyte–marrow scintigraphy.
Antigranulocyte scintigraphy (AGS) with monoclonal
antibodies or antibody fragments may be another attractive
approach to detect prosthetic joint infection [36–38]. Unlike
combined leukocyte–marrow scintigraphy, which requires
time-consuming and potentially dangerous in vitro labeling
of autologous leukocytes, AGS allows in vivo labeling of
granulocytes in the inflamed tissue surrounding the pros-
thesis [36–38]. A recent metaanalysis on the diagnostic
performance of AGS included 13 studies with a total
sample size of 522 prostheses and reported independent
random effects summary estimates of sensitivity and
specificity of 83% and 80%, respectively [38]. Future
studies are required to compare the diagnostic performance
of combined leukocyte–marrow scintigraphy, FDG-PET,
and AGS and to assess which imaging modality is most
cost-effective.
In conclusion, in this metaanalysis, overall diagnostic
performance of FDG-PET was moderate to high. Caution is
warranted, however, because results of individual studies
were heterogeneous and could not be fully explored. Future
studies should further explore causes of heterogeneity and
validate the use of FDG-PET for diagnosing prosthetic joint
infection.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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